Gracell Biotechnologies Inc - ESG Rating & Company Profile powered by AI
This Disclosure rating includes seventeen United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Industry, Innovation & Infrastructure' and 'Life below Water'. The webpage is a zero-cost ESG assessment for Gracell Biotechnologies Inc. Other corporations in the rating peer group for Gracell Biotechnologies Inc are shownin the table.
Gracell Biotechnologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.1; made up of an environmental score of 4.8, social score of 1.6 and governance score of 2.7.
3.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1733 | Timber Pharmaceuticals Inc | 3.2 | Medium |
| 1733 | Zhejiang Jiuzhou Pharmaceutical Co Ltd | 3.2 | Medium |
| 1760 | Gracell Biotechnologies Inc | 3.1 | Medium |
| 1760 | Anygen Co Ltd | 3.1 | Medium |
| 1760 | AptaBio Therapeutics Inc | 3.1 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Gracell Biotechnologies Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Gracell Biotechnologies Inc report the average age of the workforce?
Sign up for free to unlockDoes Gracell Biotechnologies Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Gracell Biotechnologies Inc offer flexible work?
Sign up for free to unlockDoes Gracell Biotechnologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Gracell Biotechnologies Inc conduct supply chain audits?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Gracell Biotechnologies Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose water use targets?
Sign up for free to unlockDoes Gracell Biotechnologies Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Gracell Biotechnologies Inc have a product recall in the last two years?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Gracell Biotechnologies Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Gracell Biotechnologies Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose parental leave metrics?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Gracell Biotechnologies Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Gracell Biotechnologies Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Gracell Biotechnologies Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose its waste policy?
Sign up for free to unlockDoes Gracell Biotechnologies Inc report according to TCFD requirements?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose energy use targets?
Sign up for free to unlockDoes Gracell Biotechnologies Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Gracell Biotechnologies Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Gracell Biotechnologies Inc
These potential risks are based on the size, segment and geographies of the company.
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019F, a FasTCAR-enabled CD19-directed autologous CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult B cell acute lymphoblastic leukemia (B-ALL), as well as in preclinical stage for the treatment of relapsed or refractory (r/r) B cell non-Hodgkin's lymphoma (B-NHL); and GC027, a TruUCAR-enabled CD7-directed allogeneic CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult T cell acute lymphoblastic leukemia. The company's product candidates also comprise GC007g, a donor-derived CD19-directed allogeneic CAR-T cell therapy that is in Phase 1/2 registrational trial clinical trial for the treatment of r/r B-ALL; and GC502, a TruUCAR-enabled dual CD19- and CD7 -directed, off-the-shelf allogeneic CAR-T product candidate, which is in Phase I trial for the treatment of B-cell malignancies. In addition, it has a portfolio of earlier stage product candidates targeting various cancer indications, such as ovarian cancer, breast cancer, peripheral T cell lymphoma, a subtype of NHL, and T cell lymphoblastic leukemia. The company was founded in 2017 and is headquartered in Suzhou, China.